Search Results

Filter
  • 1-10 of  419 results for ""Quinoxalines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis.

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/therapeutic use ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/adverse effects ; Sulfonamides*/Sulfonamides*/Sulfonamides*/therapeutic use

  • Source: Advances in therapy [Adv Ther] 2024 Dec; Vol. 41 (12), pp. 4669-4682. Date of Electronic Publication: 2024 Oct 29.Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Real-world experience in treatment of donor-derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care.

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage

  • Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2024 Dec; Vol. 26 (6), pp. e14366. Date of Electronic Publication: 2024 Sep Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Phase 1 study of safety and tolerability of an oral contraceptive containing low-dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women.

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/adverse effects ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/administration & dosage ; Quinoxalines*/Quinoxalines*/Quinoxalines*/adverse effects

  • Source: Journal of viral hepatitis [J Viral Hepat] 2024 Jul; Vol. 31 (7), pp. 409-415. Date of Electronic Publication: 2024 Apr 23.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

  • Authors : Ruiz-Cobo JC; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Subjects: Hepatitis C, Chronic*/Hepatitis C, Chronic*/Hepatitis C, Chronic*/drug therapy ; Heterocyclic Compounds, 4 or More Rings*/Heterocyclic Compounds, 4 or More Rings*/Heterocyclic Compounds, 4 or More Rings*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (2), pp. 201-211. Date of Electronic Publication: 2024 May 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal.

  • Authors : Vera J; Centro Hospitalar Barreiro-Montijo. Barreiro. Portugal.; Gomes A

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/therapeutic use ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/adverse effects ; Hepatitis C, Chronic*/Hepatitis C, Chronic*/Hepatitis C, Chronic*/drug therapy

  • Source: Acta medica portuguesa [Acta Med Port] 2024 May 02; Vol. 37 (5), pp. 323-333. Date of Electronic Publication: 2024 Feb 07.Publisher: Centro Editor Livreiro da Ordem dos Médicos Country of Publication: Portugal NLM ID: 7906803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

[Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C].

  • Authors : Sánchez Suárez MM; Martín Roldán A; Alicia Martín Roldán, Hospital Universitario Virgen de las Nieves. Postal address: Avenida de las Fuerzas Armadas, 2, 18014, Granada, Spain. .

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/therapeutic use

  • Source: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Jun; Vol. 37 (3), pp. 283-284. Date of Electronic Publication:Publisher: Sociedad Española de Quimioterapia Country of Publication: Spain NLM ID: 9108821 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Outcomes of Kidneys Transplanted From Hepatitis C Viremic Donors to Naive Recipients From an Appalachian Rural Kidney Transplant Program.

  • Authors : Gillis B; From the Department of Transplant Surgery, West Virginia University School of Medicine, Morgantown, West Virginia, USA.; Villanueva D

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/mortality ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation [Exp Clin Transplant] 2024 Mar; Vol. 22 (3), pp. 185-188.Publisher: Bas̜kent University Country of Publication: Turkey NLM ID: 101207333 Publication Model: Print Cited Medium: Internet ISSN: 2146-8427

Record details

×
Academic Journal

Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study.

  • Authors : Mizuochi T; Department of Pediatrics and Child Health, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 8300011, Japan. .; Iwama I

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis C, Chronic* ; Pyrrolidines*/Pyrrolidines*/Pyrrolidines*/therapeutic use

  • Source: Journal of gastroenterology [J Gastroenterol] 2023 Apr; Vol. 58 (4), pp. 405-412. Date of Electronic Publication: 2023 Feb 15.Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Novel Synthetic Routes to Prepare Biologically Active Quinoxalines and Their Derivatives: A Synthetic Review for the Last Two Decades.

  • Authors : Khatoon H; Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia.; Abdulmalek E

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/chemical synthesis ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Molecules (Basel, Switzerland) [Molecules] 2021 Feb 18; Vol. 26 (4). Date of Electronic Publication: 2021 Feb 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Elbasvir and grazoprevir for the treatment of hepatitis C.

  • Authors : Wang SJ; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Yuan's General Hospital, Kaohsiung, Taiwan.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Benzofurans/Benzofurans/Benzofurans/*administration & dosage ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2021 Sep; Vol. 19 (9), pp. 1071-1081. Date of Electronic Publication: 2021 Jan 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101181284 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  419 results for ""Quinoxalines""